Peptide Blog

Semaglutide peptide is a novel glucagon-like peptide-1 (GLP-1) receptor agonist. It has emerged as an innovative compound within the realm of type 2 diabetes mellitus and obesity research. This article provides an overview of Semaglutide, its proposed mechanism of action, essential functions, historical development, and research data. Semaglutide peptide is a synthetic analog of glucagon-like...

B7-33, a monomeric peptide, represents a synthetic derivation in soluble form from the endogenous protein H2-relaxin. This innovative peptide appears to retain the intrinsic anti-fibrotic attributes of relaxin, and researchers suggest it may strategically avoid the upregulation of cyclic adenosine monophosphate (cAMP) production. Beyond these foundational proposed characteristics, B7-33 appears to exhibit the unique potential...

Scientific investigations have suggested that the blend of GHRP-2 and CJC-1295 peptides may be associated with the activation of discrete receptors, fostering the potential augmentation of growth hormone (GH) discharge from the anterior pituitary. CJC-1295 represents a molecular entity that appears to exhibit a binding affinity for the growth hormone-releasing hormone (GHRH) receptors, thereby potentially...

Tesamorelin and Ipamorelin represent two distinct synthetic growth hormone-releasing peptides (GHRPs) that have garnered considerable attention in the realm of biochemical research. Both compounds, Tesamorelin and Ipamorelin, appear to possess the potential to stimulate the release of endogenous growth hormone (GH) through the activation of the ghrelin receptor. This unique action has spurred increasing scientific...

GHK, a tripeptide constituting the amino acid sequence glycine-histidine-lysine, appears to be ubiquitously found in plasma, saliva, and urine, exhibiting an age-related decline. In the context of plasma, GHK concentrations are suggested to be present at levels of approximately 200 ng/mL during early adulthood; however, these concentrations are speculated to diminish to approximately 80 ng/mL...

Thymosin Beta 4 (TB4) is a naturally occurring peptide. It consists of 43 amino acids and research suggests that it may appear in high concentrations in various cell lines, including blood platelets and lymphocytes. Synthetic Thymosin Beta 4 is also known as TB-500. Research studies suggest that Thymosin Beta 4 may exhibit some potential to...

Chonluten, also known as EDG tripeptide or T-34, is a short peptide made of 3 amino acids that may act as a potential bioregulator of gene expression. More specifically, it is made of the amino acids glycine, glutamine, and asparagine with the following configuration: Glu-Asp-Gly. According to laboratory research, Chonluten (T-34) may be derived from...

The CJC-1295 and GHRP-6 blend combines two peptides that may interact with calls in the pituitary gland and the hypothalamus called somatotrophs. These cells are thought to play a role in growth hormone synthesis and regulation. More specifically, the blend consists of CJC-1295, an apparent growth hormone-releasing hormone (GHRH) analog, and GHRP-6 (Growth Hormone Releasing...

The BPC-157 & TB-500 blend incorporates two synthetic peptides with very different structures but similar research potential. TB-500 is a synthetic version of the thymosin beta-4 (Tβ4) peptide that naturally occurs in the cells of the thymus gland. It is made of 43 amino acids encoded by the TMSB4X gene. The peptide has the following...